Erin E. Swirczynski

• Successfully launched two gMG (generalized Myasthenia Gravis) products, contributing to their national recognition and market penetration
• Collaborated with cross-functional teams to ensure the successful execution and delivery of product launches
• Demonstrated expertise in product strategy and market analysis, optimizing growth and customer engagement
• Collaborated with external and internal stakeholders to ensure a positive patient and account experience with Rystiggo and Zilbrysq

Sales Accomplishments

• 2024 Pinnacle Award Winner
• 2023 Rank 10/60
• 58 new patient referrals in 2024
• Currently ranked #1 for 2025 through April

• Responsible for sales of CSL Behring's portfolio of immunoglobulin products, Privigen and Hizentra in Allergy/Immunology and Neurology
• Actively works with patient support groups (GBS/CIDP local chapter and currently representing CSL for the Immune Deficiency Foundation's national educational forum
• Closely collaborated with internal partners in order to optimize patient experience
• Collaborated with specialty pharmacies to ensure successful pull-through
• Promoted to National Field Trainer 2021
• Have participated in the training process for 25% of current sales force

Sales Accomplishments

• Top 15% final rank 22/23 FY
• #1 Hizentra Product Award FY 2017/2018
• #2 Overall National Ranking FY 2017/2018
• #2 National Ranking for Haegarda Product Launch 2017
• #1 Hizentra Product Award FY 2016/2017
• #5 Overall National Ranking FY 2016/2017
• Hizentra Leading the Way National Contest 1st place winner FY 2017/2018 achieving 234% to goal
• National Leader for CIDP new starts during neurology launch, securing 33 new patients starts which represented highest patient count in the nation
• Final Rank 10/67 FY 2021/2022

• Responsible for sales of Xarelto, Invokana, and Invokamet in the Mesa East territory
• Successfully launched new SGLT2 Inhibitor, Invokana (2013) and combination product, Invokamet (2014)
• Served as the central point of contact to leverage and develop strong relationships, strong account management skills, and influencing critical stakeholders within medical groups such as the Arizona Commonwealth ACO
• Served as district training lead

Sales Accomplishments

• National Contest winner for largest increase in new prescribers for Invokana Q4 2013
• Achieved Formulary for Xarelto through collaboration with internal and external business partners at Mt
• Graham Hospital in Safford, 2013
• Xarelto New Business Development Award Winner Q3 2013

• Successfully launched new anticoagulant, Xarelto, with three indications: Orthopedic Surgery, Stroke Prevention in Afib, and DVT/PE treatment
• Implementing brand awareness and fostering new prescribers targeting Orthopedic Surgeons, Cardiologists, Neurologists, and Primary Care
• Successfully launched Nucynta and Nucynta ER into the pain market, focusing on Pain Specialist, Internists, and Orthopedist
• Applied a wide range of value-based consultative selling skills to launch new indications of Nucynta ER into marketplace for quick adoption by leveraging customer relationships to further penetrate accounts and build product support
• Experience in selling in pain, cardiology, gastroenterology, and anti-infective markets

Sales Accomplishments

• 2011 Presidents Circle Winner (221% overall PQ ) - Ranked 64/966 nationally
• Regional Business Director Award recipient
• Ranked 284/924 nationally for Nucynta volume growth
• Awarded Aciphex Share Leaders, September 2010